Compare CORT & FULT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CORT | FULT |
|---|---|---|
| Founded | 1998 | 1882 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 4.6B |
| IPO Year | 2001 | 1995 |
| Metric | CORT | FULT |
|---|---|---|
| Price | $113.86 | $23.40 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $96.50 | $21.75 |
| AVG Volume (30 Days) | 710.8K | ★ 1.3M |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.55% |
| EPS Growth | N/A | ★ 32.48 |
| EPS | 0.09 | ★ 1.02 |
| Revenue | ★ $761,407,000.00 | $276,768,000.00 |
| Revenue This Year | $26.08 | $6.39 |
| Revenue Next Year | $26.98 | $5.52 |
| P/E Ratio | $1,266.44 | ★ $23.16 |
| Revenue Growth | ★ 12.79 | N/A |
| 52 Week Low | $28.66 | $16.60 |
| 52 Week High | $126.38 | $25.23 |
| Indicator | CORT | FULT |
|---|---|---|
| Relative Strength Index (RSI) | 53.22 | 42.11 |
| Support Level | $77.73 | $23.15 |
| Resistance Level | $124.30 | $24.86 |
| Average True Range (ATR) | 4.47 | 0.34 |
| MACD | -1.50 | -0.01 |
| Stochastic Oscillator | 31.10 | 28.36 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.